Special Issue "Cancer Vaccines: Research and Applications"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 November 2018).
Interests: vaccines; immunology; autoimmunity; cancer; chronic diseases; exercise; mental health; immunotherapy
Special Issues and Collections in MDPI journals
Special Issue in Vaccines: Therapeutic Approaches for Type 1 and Type 2 Diabetes
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series I
Special Issue in Vaccines: Multiple Sclerosis and Its Complications: Clinical Trials
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series II
Special Issue in Vaccines: Vaccines for Infectious and Chronic Diseases
Special Issue in International Journal of Molecular Sciences: Complimentary Medicine for the Treatment of Chronic and Infectious Diseases
Special Issue in Biologics: Anti-SARS-CoV-2/COVID-19 Drugs and Vaccines
Special Issue in Vaccines: Multiple Sclerosis, Complications and Therapeutics 2.0
Designing cancer vaccines has been at the forefront of cancer research for over 2 decades. In particular delivery methods used to stimulate effective and long lasting immune responses has been the major focus. This special issue will focus on delivery methods used for cancer vaccines and their outcomes in preclinical studies and clinical trials.
Prof. Dr. Vasso Apostolopoulos
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cancer vaccines
- Delivery methods
- Dendritic cells
- Particulate vaccines
- Peptide based vaccines
- DNA vaccines
- T cell responses
- Clinical outcomes
- Clinical trials
- Antigen processing
- Antigen presentation
- MHC-T cell interaction